COMMUNIQUÉS West-GlobeNewswire

-
NOTICE IN RELATION TO THE CONVERTIBLE BONDS DUE MAY 2020
25/05/2018 -
Medibio Corporate Health Extends Global Footprint Signing Contract with Jacobs Engineering
25/05/2018 -
Medtronic EVP & Chief Financial Officer Karen L. Parkhill to Speak at Jefferies 2018 Global Healthcare Conference
25/05/2018 -
Coherus BioSciences Announces New Employment Inducement Grants
25/05/2018 -
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
25/05/2018 -
Marrone Bio Innovations, Inc. to Present at 8th Annual LD Micro Invitational Investor Conference in Los Angeles
25/05/2018 -
Vericel to Present at the Jefferies 2018 Global Healthcare Conference
25/05/2018 -
Emory Healthcare and Sharecare to launch Emory Healthcare Innovation Hub
25/05/2018 -
CORRECTION : Hydropothecary annonce le devancement de l'échéance de bons de souscription
25/05/2018 -
Microbot Medical Closes Acquisition of Novel Technology from CardioSert Ltd.
25/05/2018 -
Oncolytics Biotech® Announces Research Collaboration with the Keck School of Medicine of USC Combining REOLYSIN® with Keytruda®, Velcade® and Dexamethasone
25/05/2018 -
Midatech commences US clinical study of its investigational treatment for fatal childhood brain cancer
25/05/2018 -
Protalix BioTherapeutics Announces Poster Presentation on Baseline Characteristics for Fabry Disease Patients Screened in the Phase III BALANCE Study of Pegunigalsidase Alfa at the 55th ERA-EDTA Congress
25/05/2018 -
Avivagen to Pursue Regulatory Approval in Mexico
25/05/2018 -
Keryx Biopharmaceuticals Announces Data from an Investigator Sponsored Trial of Ferric Citrate in Patients with Advanced Chronic Kidney Disease in a Late-Breaking Presentation at the 55th Annual ERA/EDTA Today in Copenhagen
25/05/2018 -
CVs of Proposed Members of the Council of JSC Olainfarm
25/05/2018 -
MyoGen : Les leaders d’une révolution anabolique
25/05/2018 -
Bardoxolone Methyl Improved Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease and IgA Nephropathy in the Ongoing Phase 2 Phoenix Study
25/05/2018 -
NeuroSearch A/S: Publication of offer document
25/05/2018
Pages